ScourGuard 4KC

---

ScourGuard® 4KC has been demonstrated to be effective against diarrhea in calves caused by bovine rotavirus (serotypes G6 and G10), bovine coronavirus, Escherichia coli (E. coli) and Clostridium perfringens Type C when calves nurse vaccinated dams. 

---

Additional Product Information

• Only vaccine with demonstrated rotavirus G10 protection.*
  
• First and only vaccine with label protection for both rotavirus G6 and G10 serotypes.*
• Significantly increases antibody concentrations to rotavirus G10 in the colostrum.1
• Compared with unvaccinated controls, ScourGuard® 4KC has been shown to reduce mortality caused by E. coli by 95%.
• Helps prevent enterotoxemia from Clostridium perfringens
• *as indicated by USDA label claims
• Efficacy of the bovine rotavirus fraction was demonstrated in two challenge studies conducted by Zoetis. When challenged with either bovine rotavirus serotype G6 or G10, calves fed colostrum from heifers vaccinated with ScourGuard® 4KC ¬showed significant reductions in abnormal fecal, appetite, attitude and dehydration scores when compared with calves consuming colostrum from unvaccinated control cows.
• Efficacy of the bovine coronavirus fraction was demonstrated in a challenge study. Following challenge, calves that received colostrum from vaccinated cows had significant reductions in mortality and abnormal appetite, attitude and dehydration scores when compared with calves consuming colostrum from unvaccinated control cows.
• Efficacy of the E. coli K99 fraction was demonstrated in an additional study, designed similarly to the previous studies. Following challenge, 95% of calves (19 of 20) receiving colostrum from cows previously vaccinated with the E. coli fraction were protected. In contrast, 100% of calves (eight of eight) receiving colostrum from unvaccinated control cows died within 48 hours of challenge.
• Efficacy of the Cl. perfringens Type C component was demonstrated by showing that other fractions of ScourGuard 4KC did not interfere with the protective response stimulated by the Cl. perfringens Type C fraction.
• General Directions: Vaccination of healthy, pregnant cows and heifers is recommended. Mix well. Aseptically administer 2 mL intramuscularly (IM) only. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck.
• Primary Vaccination: Administer two IM doses approximately three weeks apart to pregnant cows, with the second dose given three to six weeks before calving.
• Revaccination: Revaccination with a single dose three to six weeks before each subsequent calving is recommended. Good animal husbandry and herd-health management practices, including biosecurity, infectious disease control and annual revaccination should be employed.

---

INQUIRY FORM